YPW-12174-50274
3 vaccinations
4 coded responses
25 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 201 / VA
- Registered
- 2021-05-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Dose 1 — Moderna
-
2021-05-10
Dose 2 — Moderna
-
2021-05-12
Registered in v-safe
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-13
-
2021-05-17
Survey response — day 7, dose 2MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
- 2021-06-01
- 2021-06-07
- 2021-06-14
- 2021-06-21
-
2021-08-10
Survey response — 3 months, dose 2MedDRA: Chest discomfort, Nausea, Respiratory tract congestion — Feeling: FairFree text: Congestion, nausea, tight chest.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-08
-
2022-01-11
Dose 3 — Moderna
-
2022-01-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-01-13
-
2022-01-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2022-01-15
- 2022-01-16
- 2022-01-17
- 2022-01-18
-
2022-01-25
Survey response — day 14, dose 3MedDRA: Premature labour — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Had early contractions.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — day 14, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-01-26
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-02
- 2022-02-08
- 2022-02-15
- 2022-02-22
- 2022-04-13
- 2022-07-14
-
2023-01-11
Survey response — 12 months, dose 3MedDRA: Anal incontinence, Arthralgia, Flatulence, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-11
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Moderna | |
| 2 | 2021-05-10 | Moderna | |
| 3 | 2022-01-11 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-25 | Successful 2022-01-26 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2023-01-11 | Unsuccessful |
Free text
Release 8 — day 7, dose 2
Systemic reaction (other): Cough
Release 9 — 3 months, dose 2
Symptoms: Congestion, nausea, tight chest.
Release 11 — day 14, dose 3
Symptoms: Had early contractions.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Anal incontinence | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Chest discomfort | ✓ | · | ✓ |
| SD | Flatulence | · | · | ✓ |
| SD | Nausea | ✓ | · | ✓ |
| SD | Premature labour | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release